Potential synergistic action of 19 schizophrenia risk genes in the thalamus.

A goal of current schizophrenia (SZ) research is to understand how multiple risk genes work together with environmental factors to produce the disease. In schizophrenia, there is elevated delta frequency EEG power in the awake state, an elevation that can be mimicked in rodents by N-methyl-d-aspartate receptor (NMDAR) antagonist action in the thalamus. This thalamic delta can be blocked by dopamine D2 receptor antagonists, agents known to be therapeutic in SZ. Experiments suggest that these oscillations can interfere with brain function and may thus be causal in producing psychosis. Here we evaluate the question of whether well-established schizophrenia risk genes may interact to affect the delta generation process. We identify 19 risk genes that can plausibly work in a synergistic fashion to generate delta oscillations.
Competing Interests: John Lisman received speaker’s honoraria from Pfizer Pharmaceuticals and Roche Pharmaceuticals. Edwin A. Richard, Elizaveta Khlestova and Roshan Nanu report no potential conflicts of interest.
(Copyright © 2016 Elsevier B.V. All rights reserved.)